Akanocure Pharmaceuticals INC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.0Mattributed |
|---|---|
| Latest round | strategic, $1.0M, 2024-01-01attributed |
| Founded | 2020 |
| Headquarters | West Lafayette, USA |
| Industry | pharmaceuticals |
| Stage | series-b+ |
| Website | akanocure.com |
Akanocure develops novel small-molecule drugs targeting orphan and unmet oncology indications. It serves clinicians and patients facing metastatic cancers (90% of cancer deaths). Differentiator: combines chemistry-methodology expertise with classic drug-discovery practices.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | strategic | $1.0M | undisclosed |
Detected tech stack
GoDaddy Website Builder 7.0.5350
Provenance
| Fact | Status | Basis |
|---|---|---|
| Strategic, $1.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | akanocure.com, read 2026-05-02 |
| Description | self-reported | akanocure.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.